Although OD's profitability remained at impressively high levels, its OR deteriorated 140 basis points to 73.4% in 2024. This was due to sluggish underlying demand for most of the year (lost leverage) ...

Q4 2025 Earnings Call Transcript July 31, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.55, expectations were $2.49. Operator: Hello, and welcome to the Q4 Fiscal Year 2025 ResMed ...

Interface design software company Figma made a stellar debut on the public markets on Thursday, with its stock soaring more ...

Looking for the latest stock opportunities in August 2025? Click to read these top stock picks to consider adding to your ...

Discover how Climb Global Solutions achieved double-digit growth in Q2 2025 with strategic M&As, efficient ERP rollout & expanding vendor partnerships.